Soft Tissue Repair Market Forecasts to 2028 – Global Analysis By Product (Fixation Devices, Mesh, Laparoscopic Instruments), End User (Ambulatory Surgical Centers, Clinics, Hospitals) and By Geography
According to Stratistics MRC, the Global Soft Tissue Repair Market is accounted for $19.98 billion in 2020 and is expected to reach $41.30 billion by 2028 growing at a CAGR of 9.5% during the forecast period. The increasing healthcare expenditure & lack of substitutes for soft tissue repair surgery are the factors driving the market growth. However, the high cost of surgical procedures is hampering the growth of the market.
Soft tissue injuries involve damage to muscles, tendons, and ligaments that result in pain and inflammation. The soft tissue repair process is characterized by replacing the injured or damaged tissues with healthy tissues. The current treatment options rely heavily on surgical procedures, which have a low success rate. Therefore, it is imperative to find superior, technologically advanced alternatives such as minimally invasive procedures and rapid healing products.
Based on the type, the orthopedic repair segment is going to have lucrative growth during the forecast period due to the growing number of trauma and sports-related injury cases worldwide. By geography, North America is going to have high growth during the forecast period due to the well-established healthcare infrastructure and increased awareness regarding potential benefits of soft tissue repair and the products utilized in the procedures.
Some of the key players profiled in the Soft Tissue Repair Market include American Medical Systems Inc, Arthrex, Inc, C.R. Bard, Inc, Covidien plc, CryoLife, Inc, Integra Lifesciences Corporation, Johnson & Johnson, LifeCell Corporation, Lifenet Health, Inc, Medtronic Plc, Organogenesis, Smith & Nephew plc , Stryker Corporation, Wright Medical Technology, and Zimmer Biomet Holdings, Inc.
Estimated Market Size in 2020:
USD 19.98 billion
Compound Annual Growth Rate (CAGR) from 2020 to 2028:
Predicted 2028 Value:
USD 41.30 billion
Tables, Graphs & Figures
Product, Type, Application, End User, and Region
Core Drivers and Opportunities:
Restraining Factors & Market Threats:
• Fixation Devices
• Mesh/Tissue Patch
• Cell Therapy
• Laparoscopic Instruments
• Breast Augmentation/Breast Reconstruction
• Dental Repair/Reconstruction
• Cardiovascular Surgery
• Hernia Repair
• Orthopedic Repair
• Head & Neck Product
• Pelvic & Vaginal Prolapse Repair
• Skin Repair
• Tissue Matrix
• Tissue Scaffold
End Users Covered:
• Ambulatory Surgical Centers
• Research & Academic Institute
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2054 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Key Questions Answered In The Report
The Global Soft Tissue Repair Market is majorly driven by the increasing healthcare expenditure & lack of substitutes for soft tissue repair surgery.
The mesh/tissue patch segment is growing at a highest CAGR owing to the growing usage of biologic mesh and synthetic mesh for various applications.
North America dominated with a significant market share due to the factors such as availability of sophisticated healthcare facilities and rising number of trauma cases.
Asia Pacific market is growing at a highest CAGR owing to the increasing geriatric population and the rising number of patients with soft tissue injuries.
Key players in Soft Tissue Repair Market include American Medical Systems Inc, Arthrex, Inc, C.R. Bard, Inc, Covidien plc, CryoLife, Inc, Integra Lifesciences Corporation, Johnson & Johnson, LifeCell Corporation, Lifenet Health, Inc, Medtronic Plc, Organogenesis, Smith & Nephew plc, Stryker Corporation, Wright Medical Technology, and Zimmer Biomet Holdings, Inc.
Select License Type
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.